Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing oxycodone hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 5mg/5mL s/f liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 10mg/mL concentrate s/f liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely oxycodone hydrochloride 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely oxycodone hydrochloride 20 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 10mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 20mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 40mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 80mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 160mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely oxycodone hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 20 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Acetaminophen + oxycodone hydrochloride 325mg/5mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Acetaminophen + oxycodone hydrochloride 500mg/5mg caplets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing oxycodone hydrochloride and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing aspirin and oxycodone hydrochloride and oxycodone terephthalate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 10mg/mL injection solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 10mg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Aspirin + oxycodone hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 7.5 mg and paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely oxycodone hydrochloride 10 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 7.5 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 10 mg and paracetamol 650 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 10 mg and paracetamol 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 7.5 mg and paracetamol 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 10 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 7.5 mg and paracetamol 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 30mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 15mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 60mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely oxycodone hydrochloride 5 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely oxycodone hydrochloride 5 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 10 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely oxycodone hydrochloride 20 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely oxycodone hydrochloride 20 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 15 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 30 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely oxycodone hydrochloride 10 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 7.5 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Oxycodone hydrochloride 7.5 mg and paracetamol 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Oxycodone hydrochloride 10 mg and paracetamol 650 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 10 mg and paracetamol 650 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 10 mg and paracetamol 300 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Oxycodone hydrochloride 10 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 10 mg and paracetamol 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 7.5 mg and paracetamol 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Oxycodone hydrochloride 7.5 mg and paracetamol 300 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely oxycodone hydrochloride 10 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely oxycodone hydrochloride 10 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 10 mg and paracetamol 650 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Oxycodone hydrochloride 7.5 mg and paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Oxycodone hydrochloride 7.5 mg and paracetamol 325 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
3 |
Oxycodone hydrochloride 10 mg and paracetamol 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Oxycodone hydrochloride 10 mg and paracetamol 300 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Oxycodone hydrochloride 7.5 mg and paracetamol 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 7.5 mg and paracetamol 400 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Oxycodone hydrochloride 160mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 20 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 20 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely oxycodone hydrochloride 15 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely oxycodone hydrochloride 15 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxycodone hydrochloride (substance) |
Inferred relationship |
Some |
1 |